In Narrow Vote, ODAC Votes Against Avastin In Breast Cancer
This article was originally published in The Pink Sheet Daily
Executive Summary
Oncologic Drugs Advisory Committee expresses concerns about overall survival, toxicity and study conduct.
You may also be interested in...
Avastin Breast Cancer Approval In Spotlight With AVADO
CHICAGO - First placebo-controlled, double-blinded evidence for bevacizumab in first-line metastatic breast cancer presented at ASCO.
Avastin Breast Cancer Approval In Spotlight With AVADO
CHICAGO - First placebo-controlled, double-blinded evidence for bevacizumab in first-line metastatic breast cancer presented at ASCO.
Genentech’s First Quarter Solid, Avastin Slow
Breast-cancer push not yet in full swing, company says.